Items where Author is "Turner, MD"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 43.

Journal article

Turner, MD ORCID: 0000-0001-7175-1053, 2017. The identification of TNFR5 as a therapeutic target in diabetes. Expert Opinion on Therapeutic Targets. ISSN 1472-8222

Bagnati, M, Ogunkolade, BW, Marshall, C, Tucci, C, Hanna, K, Jones, TA, Bugliani, M, Nedjai, B, Caton, PW, Kieswich, J, Yaqoob, MM, Ball, GR ORCID: 0000-0001-5828-7129, Marchetti, P, Hitman, GA and Turner, MD ORCID: 0000-0001-7175-1053, 2016. Glucolipotoxicity initiates pancreatic β-cell death through 1 tumour necrosis factor receptor 5 (TNFR5 / CD40) mediated 2 STAT1 and NF-κB activation. Cell Death and Disease, 7, e2329. ISSN 2041-4889

Somanath, S, Partridge, CJ, Marshall, C, Rowe, T and Turner, MD ORCID: 0000-0001-7175-1053, 2016. Snapin mediates insulin secretory granule docking, but not trans-SNARE complex formation. Biochemical and Biophysical Research Communications, 473 (2), pp. 403-407. ISSN 0006-291X

Turner, MD ORCID: 0000-0001-7175-1053, Nedjai, B, Hurst, T and Pennington, DJ, 2014. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1843 (11), pp. 2563-2582. ISSN 0167-4889

Turner, MD ORCID: 0000-0001-7175-1053, Chaudhry, A and Nedjai, B, 2012. TNFR1 trafficking dysfunction opens the TRAPS door to proinflammatory cytokine secretion. Bioscience Reports, 32, pp. 105-112.

Dominguez, V, Raimondi, C, Somanath, S, Bugliani, M, Loder, MK, Edling, CE, Divecha, N, da Silva-Xavier, G, Marselli, L, Persaud, SJ, Turner, MD ORCID: 0000-0001-7175-1053, Rutter, GA, Marchetti, P, Falasca, M and Maffucci, T, 2011. Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells. Journal of Biological Chemistry, 286, pp. 4216-4225.

Turner, MD ORCID: 0000-0001-7175-1053 and Chernajovsky, Y, 2011. Comment on: Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology, pp. 1525-1526.

Nedjai, B, Hitman, GA, Church, LD, Minden, K, Whiteford, ML, McKee, S, Stjernberg, S, Pettersson, T, Ranki, A, Hawkins, P, Arkwright, PD, McDermott, MF and Turner, MD ORCID: 0000-0001-7175-1053, 2011. Differential cytokine secretion resulting from p65 and c-Rel NF-kappaB subunit signaling in peripheral blood mononuclear cells of TNFR-associated periodic fever syndrome patients. Cell Immunology, 268, pp. 55-59.

Nedjai, B, Quillinan, N, Coughlan, RJ, Church, L, McDermott, MF, Hitman, GA and Turner, MD ORCID: 0000-0001-7175-1053, 2011. Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A. Advances in Experimental Medicine and Biology, 691, pp. 409-419.

Persaud, SJ, Arden, C, Bergsten, P, Bone, AJ, Brown, J, Dunmore, S, Harrison, M, Hauge-Evans, A, Kelly, C, King, A, Maffucci, T, Marriott, CE, McClenaghan, N, Morgan, NG, Reers, C, Russell, M, Turner, MD ORCID: 0000-0001-7175-1053, Willoughby, E, Younis, MYG, Zhi, Z and Jones, PM, 2010. Pseudoislets as primary islet replacements for research. Islets, 2, pp. 236-239.

Somanath, S, Barg, S, Marshall, C, Silwood, CJ and Turner, MD ORCID: 0000-0001-7175-1053, 2009. High extracellular glucose inhibits exocytosis by disruption of syntaxin 1A-containing lipid rafts. Biochemical and Biophysical Research Communications, 389, pp. 241-246.

Nedjai, B, Hitman, GA, Quillinan, N, Coughlan, RJ, Church, LD, McDermott, MF and Turner, MD ORCID: 0000-0001-7175-1053, 2009. Proinflammatory action of the antiinflammatory drug infliximab in TNF-receptor associated periodic syndrome. Arthritis & Rheumatism, 60, pp. 619-625.

Nejadi, B, Hitman, GA, Yousaf, N, Chernajovsky, Y, Stjernberg, S, Pettersson, T, Ranki, A, Hawkins, P, Arkwright, PD, McDermott, MF and Turner, MD ORCID: 0000-0001-7175-1053, 2008. Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome. Arthritis & Rheumatism, 58, pp. 273-283.

Turner, MD ORCID: 0000-0001-7175-1053, Hitman, GA, Nedjai, B and McDermott, M, 2008. Cell surface expression of TNFR1 in tumor necrosis factor receptor associated periodic syndrome: reply. Arthritis & Rheumatism, 58, pp. 2214-2215.

Churchman, SM, Church, LD, Savic, S, Coulthard, LR, Hayward, B, Nedjai, B, Turner, MD ORCID: 0000-0001-7175-1053, Mathews, RJ, Baguley, E, Hitman, GA, Gooi, HC, Wood, PMD, Emery, P and McDermott, MF, 2008. A novel TNFRSF1A splice mutation associated with increased NF-kappaB transcription factor activation in patients with TNF-receptor associated periodic syndrome (TRAPS). Annals of the Rheumatic Diseases, 67, pp. 1589-1595.

Turner, MD ORCID: 0000-0001-7175-1053, Fulcher, FK, Smith, BT, Velasquez, CR, Aganna, E, Partridge, CJ, Hitman, GA, Clark, A and Patel, YM, 2007. Calpain facilitates actin reorganization during glucose-stimulated insulin secretion. Biochemical and Biophysical Research Communications, 352, pp. 650-655.

Turner, MD ORCID: 0000-0001-7175-1053, 2007. Coordinated control of both insulin secretion and insulin action through calpain-10 mediated regulation of exocytosis? Molecular Genetics and Metabolism, 91, pp. 305-307.

Marshall, C, Hitman, GA, Cassell, PG and Turner, MD ORCID: 0000-0001-7175-1053, 2007. Effect of glucolipotoxicity and rosiglitazone upon insulin secretion. Biochemical and Biophysical Research Communications, 356, pp. 756-762.

Evans, JS and Turner, MD ORCID: 0000-0001-7175-1053, 2007. Emerging functions of the calpain superfamily of cysteine proteases in neuroendocrine secretory pathways. Journal of Neurochemistry, 103, pp. 849-859.

Aganna, E, Burrin, JM, Hitman, GA and Turner, MD ORCID: 0000-0001-7175-1053, 2006. Involvement of calpain and synaptotagmin Ca2+ sensors in hormone secretion from excitable endocrine cells. Journal of Endocrinology, 191.

Lara-Lemus, R, Liu, M, Turner, MD ORCID: 0000-0001-7175-1053, Scherer, P, Stenbeck, G, Iyengar, P and Arvan, P, 2006. Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cell. Journal of Cell Science, 119, pp. 1833-1842.

Turner, MD ORCID: 0000-0001-7175-1053, Cassell, PG and Hitman, GA, 2005. Calpain-10: from genome search to function. Diabetes/Metabolism Research and Reviews, 21, pp. 505-514.

Marshall, C, Hitman, GA, Partridge, CJ, Clark, A, Ma, H, Shearer, TR and Turner, MD ORCID: 0000-0001-7175-1053, 2005. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Molecular Endocrinology, 19, pp. 213-224.

Yousaf, N, Gould, DJ, Aganna, E, Hammond, L, Mirakian, RM, Turner, MD ORCID: 0000-0001-7175-1053, Hitman, GA, McDermott, M and Chernajovsky, Y, 2005. Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. Arthritis & Rheumatism, 52, pp. 2906-2916.

Turner, MD ORCID: 0000-0001-7175-1053, 2004. Fatty acyl CoA-mediated inhibition of endoplasmic reticulum assembly. Biochimica et Biophysica Acta, 1693, pp. 1-4.

Turner, MD ORCID: 0000-0001-7175-1053 and Arvan, P, 2000. Protein traffic from the secretory pathway to the endosomal system in pancreatic beta-cells. Journal of Biological Chemistry, 275, pp. 14025-14030.

Turner, MD ORCID: 0000-0001-7175-1053, Plutner, H and Balch, WE, 1997. A Rab GTPase is required for homotypic assembly of the endoplasmic reticulum. Journal of Biological Chemistry, 272, pp. 13479-13483.

Blatchford, DE, Hendry, KAK, Turner, MD ORCID: 0000-0001-7175-1053, Burgoyne, RD and Wilde, CJ, 1995. Vectorial secretion by constitutive and regulated pathways in mammary epithelial cells. Epithelial Cell Biology, 4, pp. 8-16.

Turner, MD ORCID: 0000-0001-7175-1053, Handel, SE, Wilde, CJ and Burgoyne, RD, 1993. Differential effect of brefeldin A on phosphorylation of the caseins in lactating mouse mammary epithelial cells. Journal of Cell Science, 106, pp. 1221-1226.

Rennison, ME, Kerr, M, Addey, CPV, Handel, SE, Turner, MD ORCID: 0000-0001-7175-1053, Wilde, CJ and Burgoyne, RD, 1993. Inhibition of constitutive protein secretion from lactating mouse mammary epithelial cells by FIL (Feedback Inhibitor of Lactation) a secreted milk protein. Journal of Cell Science, 106, pp. 641-648.

Turner, MD ORCID: 0000-0001-7175-1053, Wilde, CJ and Burgoyne, RD, 1992. Exocytosis from permeabilized lactating mouse mammary epithelial cells: stimulation by Ca2+ and phorbol ester, but inhibition of regulated exocytosis by GTPgammaS. Biochemical Journal, 286, pp. 13-15.

Turner, MD ORCID: 0000-0001-7175-1053, Rennison, ME, Handel, SE, Wilde, CJ and Burgoyne, RD, 1992. Proteins are secreted by both constitutive and regulated secretory pathways in lactating mouse mammary epithelial cells. Journal of Cell Biology, 117, pp. 269-278.

Burgoyne, RD, Handel, SE, Morgan, A, Rennison, ME, Turner, MD ORCID: 0000-0001-7175-1053 and Wilde, CJ, 1991. Calcium, the cytoskeleton and calpactin (annexin II) in exocytotic secretion from adrenal chromaffin and mammary epithelial cells. Biochemical Society Transactions, 19, pp. 1085-1090.

Chapter in book

Wilde, CJ, Addey, CVP, Burgoyne, RD, Clark, AJ, Handel, SE, Kerr, MA, McClenaghan, M, Rennison, ME, Simons, JP and Turner, MD ORCID: 0000-0001-7175-1053, 1994. Autocrine regulation of milk protein secretion. In: Okamura, K, ed., Animal cell technology: basic and applied aspects. Dordrecht: Kluwer Academic Publishers.

Burgoyne, RD, Handel, SE, Sudlow, AW, Turner, MD ORCID: 0000-0001-7175-1053, Kumar, S, Simons, P, Blatchford, DR and Wilde, CJ, 1994. The secretory pathway for milk protein secretion and its regulation. In: Wilde, CJ, Peaker, M and Knight, CH, eds., Intercellular signalling in the mammary gland. New York: Plenum Press.

Conference contribution

Turner, MD ORCID: 0000-0001-7175-1053, 2012. [Invited speaker]. In: OMICS International Conference on “Clinical & Cellular Immunology”, Chicago, 2012, Chicago.

Turner, MD ORCID: 0000-0001-7175-1053, 2012. [Keynote speaker]. In: OMICS International Conference on “Clinical & Cellular Immunology”, Chicago, 2012, Chicago.

Turner, MD ORCID: 0000-0001-7175-1053, 2011. [Invited speaker]. In: Advances in Inflammation and Translational Medicine, London, 2011, London.

Turner, MD ORCID: 0000-0001-7175-1053, 2010. [Invited speaker]. In: FASEB Conference on “The Biology of Calpains in Health and Disease”, Scottsdale, USA, 2010, Scottsdale, USA.

Turner, MD ORCID: 0000-0001-7175-1053, 2010. [Invited speaker]. In: UK Membrane Trafficking, London, 2010, London.

Turner, MD ORCID: 0000-0001-7175-1053, 2009. [Invited speaker]. In: 12th International TNF Conference, Madrid, 2009, Madrid.

Turner, MD ORCID: 0000-0001-7175-1053, 2005. [Invited speaker]. In: Third International Congress on “Familial Mediterranean Fever and Systemic Autoinflammatory Diseases”, Bethesda, USA, 2005, Bethesda, USA.

Turner, MD ORCID: 0000-0001-7175-1053, 2004. [Invited speaker]. In: British Society for Cell Biology Annual Conference, Canterbury, 2004, Canterbury.

This list was generated on Tue Sep 19 15:08:11 2017 UTC.